Testa, Sophie

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Pengo, V., Denas, G., Zoppellaro, G., Jose, S. P., Hoxha, A., Ruffatti, A., Andreoli, L., Tincani, A., Cenci, C., Prisco, D., et al. (2018) · Blood

Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and Management

Cited by 822

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 632

d -Dimer Testing to Determine the Duration of Anticoagulation Therapy

Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., et al. (2006) · New England Journal of Medicine

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 622

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis

Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and Management

Cited by 585

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., De Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., et al. (2011) · Blood

Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and Management

Cited by 468

Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

Pengo, V., Testa, S., Martinelli, I., Ghirarduzzi, A., Legnani, C., Gresele, P., Passamonti, S. M., Bison, E., Denas, G., Jose, S. P., et al. (2015) · Thrombosis Research

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 89

Lupus Anticoagulant Identifies Two Distinct Groups of Patients with Different Antibody Patterns

Pengo, V., Del Ross, T., Ruffatti, A., Bison, E., Cattini, M. G., Pontara, E., Testa, S., Legnani, C., Pozzi, N., Peterle, D., et al. (2018) · Thrombosis Research

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 59

Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study

Tripodi, A., Chantarangkul, V., Cini, M., Devreese, K., Dlott, J. S., Giacomello, R., Gray, E., Legnani, C., Martinuzzo, M. E., Pradella, P., et al. (2017) · Journal of Thrombosis and Haemostasis

Systemic Lupus Erythematosus ResearchClinical Laboratory Practices and Quality Control

Cited by 35

Impact of a Commercially Available DOAC Absorbent on Two Integrated Procedures for Lupus Anticoagulant Detection

Tripodi, A., Scalambrino, E., Chantarangkul, V., Paoletti, O., Clerici, M., Novembrino, C., Boscolo-Anzoletti, M., Peyvandi, F., & Testa, S. (2021) · Thrombosis Research

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 17